Optimizing the Scalable Production of Recombinant Adeno-Associated Viral Vectors for Gene Therapies

被引:0
|
作者
Tan, Evan [1 ]
Chua, Patric [1 ]
Herman, Nurul Atiqah [1 ]
Ali, Alif Sufiyan [1 ]
Soonaan, Nur Izzati [1 ]
Zhang, Wei [1 ]
Ng, Say Kong [1 ]
机构
[1] A STAR Bioproc Technol Inst, Anim Cell Bioproc, Singapore, Singapore
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
1056
引用
收藏
页码:505 / 506
页数:2
相关论文
共 50 条
  • [41] Optimization of recombinant adeno-associated viral vectors for human β-globin gene transfer and transgene expression
    Maina, Njeri
    Zhong, Li
    Li, Xiaomiao
    Zhao, Weihong
    Han, Zongchao
    Bischof, Daniela
    Aslanidi, George
    Zolotukhin, Sergei
    Aken, Kirsten A. Weigel-Van
    Rivers, Angela E.
    Slayton, William B.
    Yoder, Mervin C.
    Srivastava, Arun
    HUMAN GENE THERAPY, 2008, 19 (04) : 365 - 375
  • [42] Gene delivery in renal tubular epithelial cells using recombinant adeno-associated viral vectors
    Chen, SF
    Agarwal, A
    Glushakova, OY
    Jorgensen, MS
    Salgar, SK
    Poirier, A
    Flotte, TR
    Croker, BP
    Madsen, KM
    Atkinson, MA
    Hauswirth, WW
    Berns, KI
    Tisher, CC
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (04): : 947 - 958
  • [43] Differential myocardial gene delivery by recombinant serotype-specific adeno-associated viral vectors
    Du, LL
    Kido, M
    Lee, DV
    Rabinowitz, JE
    Samulski, RJ
    Jamieson, SW
    Weitzman, MD
    Thistlethwaite, PA
    MOLECULAR THERAPY, 2004, 10 (03) : 604 - 608
  • [44] Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders
    Mandel, RJ
    Manfredsson, FP
    Foust, KD
    Rising, A
    Reimsnider, S
    Nash, K
    Burger, C
    MOLECULAR THERAPY, 2006, 13 (03) : 463 - 483
  • [45] Strong ubiquitous micro-promoters for recombinant adeno-associated viral vectors
    Chai, Sunghee
    Norgard, Mason
    Li, Bin
    Enicks, David
    Marks, Daniel L.
    Grompe, Markus
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 29 : 504 - 512
  • [46] Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors
    Mohiuddin, I
    Loiler, S
    Zolotukhin, I
    Byrne, BJ
    Flotte, TR
    Snyder, RO
    MOLECULAR THERAPY, 2005, 11 (02) : 320 - 326
  • [47] Chromatooraphic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications
    Burova, E
    Loffe, E
    GENE THERAPY, 2005, 12 (Suppl 1) : S5 - S17
  • [48] Strong Universal Micro Promoters for Recombinant Adeno-Associated Viral (rAAV) Vectors
    Chai, Sunghee
    Wakefield, Leslie
    Norgard, Mason
    Li, Bin
    Grompe, Markus
    MOLECULAR THERAPY, 2022, 30 (04) : 74 - 74
  • [49] Advances in Large-Scale Production of Recombinant Adeno-Associated Vectors
    Negrete, Alejandro
    Urabe, Masashi Urabe
    Kotin, Robert M.
    MOLECULAR THERAPY, 2006, 13 : S195 - S195
  • [50] Development of analytical methodology for characterisation of recombinant adeno-associated viral (rAAV) vectors
    Patricio, M.
    Wong, A.
    Hassall, A.
    Chippendale, T.
    Silvano, M.
    Tam, L.
    Liu, Q.
    Payne, T.
    HUMAN GENE THERAPY, 2019, 30 (08) : A26 - A27